Jump Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Jump Trading’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,954	Closed	-$852K	–	572
2018 Q2	$852K	Buy	+8,954	New	+$823K	0.07%	152
2016 Q2	–	Sell	-5,666	Closed	-$310K	–	764
2016 Q1	$293K	Buy	5,666 +1,315	+30%	+$68.3K	0.01%	459
2015 Q4	$305K	Buy	+4,351	New	+$297K	0.01%	590
2015 Q2	–	Sell	-8,835	Closed	-$687K	–	1161
2015 Q1	$664K	Buy	+8,835	New	+$617K	0.02%	340

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Jump Trading's XBI Position: Q3 2018 in Review

Jump Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 8,954 shares — an estimated $852K sold.

Jump Trading first reported a position in XBI in Q1 2015 and held it in 4 quarters. The position peaked at $852K in Q2 2018. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

Jump Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
Jump Trading sold 8,954 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $852K.
Jump Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 4 quarters.
Jump Trading's State Street SPDR S&P Biotech ETF position peaked at $852K in Q2 2018.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Jump Trading's 13F filing for Q3 2018, filed 14 Nov 2018.